ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairment.

Viswanath Devanarayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.